The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 30.40
Bid: 29.40
Ask: 31.40
Change: 0.00 (0.00%)
Spread: 2.00 (6.803%)
Open: 30.40
High: 30.40
Low: 30.40
Prev. Close: 30.40
MIG5 Live PriceLast checked at -
Maven Income and Growth VCT 5 is an Investment Trust

To invest in a diversified portfolio of later-stage UK private companies to provide long-term capital appreciation and generate maintainable levels of income for shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

21 Apr 2015 15:08

RNS Number : 8951K
Maven Income and Growth VCT 5 PLC
21 April 2015
 

Maven Income and Growth VCT 5 PLC (the Company) - Result of Annual General Meeting

 

At the Annual General Meeting of the Company held at 10.00 am in 5th Floor 1-2 Royal Exchange Buildings, London EC3V 3LF on 21 April 2015, all of the Resolutions put to the Meeting were duly passed.

 

At the record date for the Annual General Meeting, being 17 April 2015, the total number of voting rights in the Company stood at 77,641,850 and the total shares in issue were 77,641,850. In accordance with the provisions of D.2.2 of the Combined Code on Corporate Governance, the Company advises that for the Annual General Meeting, valid proxy appointments were made in respect of 5,148,129 shares and that the number of proxy votes lodged for each Resolution were as follows:

 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Annual Report and audited Financial Statements

4,975,043

171,256

0

1,830

5,148,129

2

To approve the Directors' Remuneration Report

4,414,759

171,256

429,596

132,518

5,148,129

3

To approve a final dividend

4,970,088

169,038

4,003

5,000

5,148,129

4

To re-elect Mr G Humphries as a Director

4,803,439

169,038

107,220

68,432

5,148,129

5

To re-elect Mr A Langlands as a Director

4,843,805

169,038

64,110

71,176

5,148,129

6

To re-elect Mr C Young as a Director

4,820,978

193,233

59,851

74,067

5,148,129

7

To appoint KPMG LLP as Auditor

 

4,559,755

174,038

355,191

59,145

5,148,129

8

To authorise the Directors to fix the remuneration of the Auditor

4,894,740

169,038

58,699

25,652

5,148,129

9

To authorise the Directors to allot new shares

4,814,221

169,038

22,760

142,110

5,148,129

10

To authorise disapplication of pre-emption rights

4,469,167

176,004

347,630

155,328

5,148,129

11

To authorise the Company to purchase its own shares

4,252,012

174,063

674,032

48,022

5,148,129

12

To allow a General Meeting to be called on not less than 14 days' notice

4,789,961

179,303

152,661

26,204

5,148,129

 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. The voting figures will be available to view at: www.mavencp.com/migvct5.

 

Passing of Resolutions under Special Business

 

The Special Resolutions have been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.//hemscott.com/nsm.do.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

21 April 2015

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGIBMITMBMTBFA
Date   Source Headline
3rd May 20249:28 amRNSIssue of Equity
1st May 202410:10 amRNSIssue of Equity
26th Apr 20242:44 pmRNSUnaudited NAV - Dividend Investment Scheme
23rd Apr 20242:27 pmRNSResult of AGM
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:49 pmRNSIssue of Equity
27th Mar 202410:31 amRNSIssue of Equity
22nd Mar 20244:25 pmRNSStatement re Offer for Subscription
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:48 pmRNSUnaudited Net Asset Value
8th Mar 20242:57 pmRNSAnnual Financial Report
15th Feb 20244:45 pmRNSTransaction in Own Shares
8th Feb 202410:33 amRNSDirector/PDMR Shareholding
8th Feb 202410:12 amRNSIssue of Equity
7th Feb 20243:09 pmRNSDividend Declaration
19th Dec 20233:28 pmRNSIssue of Equity
18th Dec 20235:24 pmRNSUnaudited Net Asset Value
9th Nov 20233:51 pmRNSResult of General Meeting
20th Oct 20234:13 pmRNSTransaction in Own Shares
13th Oct 20234:56 pmRNSPublication of a Prospectus
4th Oct 20234:03 pmRNSNet Asset Value(s)
29th Aug 20239:15 amRNSDirectorate Change
24th Jul 202311:16 amRNSHalf-year Report
21st Jul 20234:43 pmRNSTransaction in Own Shares
21st Jul 20239:48 amRNSIssue of Equity
17th Jul 202310:57 amRNSNet Asset Value - Dividend Investment Scheme
11th Jul 20234:47 pmRNSNet Asset Value
6th Jul 20234:01 pmRNSStatement re Intended Offers for Subscription
14th Jun 202310:33 amRNSDividend Declaration
2nd Jun 20239:48 amRNSIssue of Equity
5th May 202310:23 amRNSIssue of Equity - Dividend Investment Scheme
27th Apr 20233:57 pmRNSTransaction in Own Shares
27th Apr 20231:04 pmRNSIssue of Supplementary Prospectus
26th Apr 202311:39 amRNSNet Asset Value - Dividend Investment Scheme
25th Apr 20233:14 pmRNSNet Asset Value(s)
25th Apr 202312:50 pmRNSResult of AGM
5th Apr 202312:32 pmRNSIssue of Equity
29th Mar 20232:19 pmRNSIssue of Supplementary Prospectus
23rd Mar 20235:18 pmRNSAnnual Financial Report
3rd Mar 20239:56 amRNSIssue of Equity
21st Feb 20234:44 pmRNSTransaction in Own Shares
8th Feb 202310:24 amRNSDirector/PDMR Shareholding
8th Feb 20239:48 amRNSIssue of Equity
1st Feb 20233:25 pmRNSUnaudited NAV and Proposed Final Dividend
9th Nov 20223:02 pmRNSResult of General Meeting
4th Nov 20223:25 pmRNSTransaction in Own Shares
26th Oct 20223:53 pmRNSTransaction in Own Shares
7th Oct 20224:28 pmRNSPublication of a Prospectus
4th Oct 20223:30 pmRNSChange of Auditor
4th Oct 20221:35 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.